AVAVA, Inc.
AVAVA, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AVAVA MIRIA General Use | Acneiform Eruptions, Fibrosis, Hypertrophy, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, severe cutaneous adverse reaction, skin disorder | Recruiting | Not applicable | 2026-09-15 | NCT06868615 | |
| AV-23-001 AVAVA MIRIA Pilot Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosis, Hypertrophy, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, severe cutaneous adverse reaction, skin disorder | Active, not recruiting | Not applicable | 2025-03-07 | NCT06557434 | |
| The MIRIA Acne Scar Study | Fibrosis, Hypertrophy, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, severe cutaneous adverse reaction | Active, not recruiting | Not applicable | 2025-03-07 | NCT05597267 |